Cargando…

Lack of autoantibodies against collagen and related proteins in collagenous colitis

INTRODUCTION: Collagenous colitis (CC) is a common cause of chronic diarrhea and is characterized by a subepithelial thickened collagen layer in the colonic mucosa. It shares many of the characteristics found in autoimmune diseases, but no autoantibodies have been identified. In CC, an imbalance in...

Descripción completa

Detalles Bibliográficos
Autores principales: JK, Larsson, B, Roth, B, Ohlsson, K, Sjöberg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171945/
https://www.ncbi.nlm.nih.gov/pubmed/35668375
http://dx.doi.org/10.1186/s12865-022-00504-5
_version_ 1784721782240968704
author JK, Larsson
B, Roth
B, Ohlsson
K, Sjöberg
author_facet JK, Larsson
B, Roth
B, Ohlsson
K, Sjöberg
author_sort JK, Larsson
collection PubMed
description INTRODUCTION: Collagenous colitis (CC) is a common cause of chronic diarrhea and is characterized by a subepithelial thickened collagen layer in the colonic mucosa. It shares many of the characteristics found in autoimmune diseases, but no autoantibodies have been identified. In CC, an imbalance in collagen turnover is evident. The purpose of the present study was to investigate whether any collagen-associated autoantibodies or other antibodies such as TPO and ASCA were present, and if levels of total IgE were increased. METHODS: Sera from women with active CC were analysed with ELISA for detection of autoantibodies against collagen type III and IV (Col III and IV), matrix metalloproteinase-9 (MMP-9), tissue inhibitors of metalloproteinase-1 (TIMP-1) and tenascin-C (TNC). Sera were also analysed for TPO, ASCA and total IgE. Healthy female blood donors served as controls. The cut-off value in the control group was defined as relative units > 97.5th percentile. RESULTS: Sixty-six women were included (mean age 60 years; range 31–74, mean disease duration 6 years; range 1–22). No autoantibody was significantly overexpressed in the CC population compared to controls. The mean disease duration was lower (p = 0.03) in the subjects who expressed collagen-associated autoantibodies (3.7 years; range 1–14), compared to those who did not (6.4 years; range 1–22). Treatment with budesonide was not associated with any of these autoantibodies. CONCLUSION: No increased presence of the investigated antibodies could be found in the present study of CC. Neither could antibodies against ASCA or TPO, or elevated levels of IgE, be found. Consequently, no association was found between CC and these proteins, even though this may not be generalizable to other compounds in the collagen layer.
format Online
Article
Text
id pubmed-9171945
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-91719452022-06-08 Lack of autoantibodies against collagen and related proteins in collagenous colitis JK, Larsson B, Roth B, Ohlsson K, Sjöberg BMC Immunol Research INTRODUCTION: Collagenous colitis (CC) is a common cause of chronic diarrhea and is characterized by a subepithelial thickened collagen layer in the colonic mucosa. It shares many of the characteristics found in autoimmune diseases, but no autoantibodies have been identified. In CC, an imbalance in collagen turnover is evident. The purpose of the present study was to investigate whether any collagen-associated autoantibodies or other antibodies such as TPO and ASCA were present, and if levels of total IgE were increased. METHODS: Sera from women with active CC were analysed with ELISA for detection of autoantibodies against collagen type III and IV (Col III and IV), matrix metalloproteinase-9 (MMP-9), tissue inhibitors of metalloproteinase-1 (TIMP-1) and tenascin-C (TNC). Sera were also analysed for TPO, ASCA and total IgE. Healthy female blood donors served as controls. The cut-off value in the control group was defined as relative units > 97.5th percentile. RESULTS: Sixty-six women were included (mean age 60 years; range 31–74, mean disease duration 6 years; range 1–22). No autoantibody was significantly overexpressed in the CC population compared to controls. The mean disease duration was lower (p = 0.03) in the subjects who expressed collagen-associated autoantibodies (3.7 years; range 1–14), compared to those who did not (6.4 years; range 1–22). Treatment with budesonide was not associated with any of these autoantibodies. CONCLUSION: No increased presence of the investigated antibodies could be found in the present study of CC. Neither could antibodies against ASCA or TPO, or elevated levels of IgE, be found. Consequently, no association was found between CC and these proteins, even though this may not be generalizable to other compounds in the collagen layer. BioMed Central 2022-06-06 /pmc/articles/PMC9171945/ /pubmed/35668375 http://dx.doi.org/10.1186/s12865-022-00504-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
JK, Larsson
B, Roth
B, Ohlsson
K, Sjöberg
Lack of autoantibodies against collagen and related proteins in collagenous colitis
title Lack of autoantibodies against collagen and related proteins in collagenous colitis
title_full Lack of autoantibodies against collagen and related proteins in collagenous colitis
title_fullStr Lack of autoantibodies against collagen and related proteins in collagenous colitis
title_full_unstemmed Lack of autoantibodies against collagen and related proteins in collagenous colitis
title_short Lack of autoantibodies against collagen and related proteins in collagenous colitis
title_sort lack of autoantibodies against collagen and related proteins in collagenous colitis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171945/
https://www.ncbi.nlm.nih.gov/pubmed/35668375
http://dx.doi.org/10.1186/s12865-022-00504-5
work_keys_str_mv AT jklarsson lackofautoantibodiesagainstcollagenandrelatedproteinsincollagenouscolitis
AT broth lackofautoantibodiesagainstcollagenandrelatedproteinsincollagenouscolitis
AT bohlsson lackofautoantibodiesagainstcollagenandrelatedproteinsincollagenouscolitis
AT ksjoberg lackofautoantibodiesagainstcollagenandrelatedproteinsincollagenouscolitis